M. L. Sa-e-melo, C. Silva, M. M. Iuliano, L. Lizard, and G. , Oxysterols and related sterols: chemical, biochemical and biological aspects, Steroids, vol.99, pp.117-118, 2015.

M. Poirot and S. Silvente-poirot, Oxysterols and related sterols: implications in pharmacology and pathophysiology, Biochem. Pharmacol, vol.86, pp.1-2, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00832422

F. R. Santori, P. Huang, S. A. Van-de-pavert, E. F. Douglass, D. J. Leaver et al., Identification of natural RORgamma ligands that regulate the development of lymphoid cells, Cell Metab, vol.21, pp.286-297, 2015.


P. Soroosh, J. Wu, X. Xue, J. Song, S. W. Sutton et al., Oxysterols are agonist ligands of RORgammat and drive Th17 cell differentiation, Proc. Natl. Acad. Sci. U.S.A, vol.111, pp.12163-12168, 2014.

A. Reboldi, E. V. Dang, J. G. Mcdonald, G. Liang, D. W. Russell et al., Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon, Science, vol.345, pp.679-684, 2014.

S. Theofilopoulos, W. J. Griffiths, P. J. Crick, S. Yang, A. Meljon et al., Cholestenoic acids regulate motor neuron survival via liver X receptors, J. Clin. Invest, vol.124, pp.4829-4842, 2014.

S. Theofilopoulos, Y. Wang, S. S. Kitambi, P. Sacchetti, K. M. Sousa et al., Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis, Nat. Chem. Biol, vol.9, pp.126-133, 2013.

F. Dalenc, M. Poirot, and S. Silvente-poirot, Dendrogenin A: a mammalian metabolite of cholesterol with tumor suppressor and neurostimulating properties, Curr. Med. Chem, vol.22, pp.3533-3549, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02380776


P. Medina, M. R. Paillasse, G. Segala, M. Voisin, L. Mhamdi et al., , 2013.

, Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties, Nat. Commun, vol.4, 1840.

M. Poirot, Four decades of discovery in breast cancer research and treatment -an interview with V. Craig Jordan, Int. J. Dev. Biol, vol.55, pp.703-712, 2011.

V. C. Jordan, Selective estrogen receptor modulation: concept and consequences in cancer, Cancer Cell, vol.5, pp.207-213, 2004.

P. De-medina, G. Favre, and M. Poirot, Multiple targeting by the antitumor drug tamoxifen: a structure-activity study, Curr. Med. Chem. Anticancer Agents, vol.4, pp.491-508, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-00090772

R. Clarke, F. Leonessa, J. N. Welch, and T. C. Skaar, Cellular and molecular pharmacology of antiestrogen action and resistance, Pharmacol. Rev, vol.53, pp.25-71, 2001.

B. Kedjouar, P. De-medina, M. Oulad-abdelghani, B. Payre, S. Silvente-poirot et al., Molecular characterization of the microsomal tamoxifen binding site, J. Biol. Chem, vol.279, pp.34048-34061, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-00090773

B. Sola, M. Poirot, P. De-medina, S. Bustany, V. Marsaud et al., Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism, Oncotarget, vol.4, pp.911-922, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00968940


G. Segala, P. De-medina, L. Iuliano, C. Zerbinati, M. R. Paillasse et al., ) 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells, Biochem. Pharmacol, vol.86, pp.175-189, 2013.


S. Silvente-poirot and M. Poirot, Cholesterol epoxide hydrolase and cancer, Curr. Opin. Pharmacol, vol.12, pp.696-703, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00743463


M. Poirot, S. Silvente-poirot, and R. R. Weichselbaum, Cholesterol metabolism and resistance to tamoxifen, Curr. Opin. Pharmacol, vol.12, pp.683-689, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00743466

P. De-medina, M. R. Paillasse, G. Segala, F. Khallouki, S. Brillouet et al., Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands, Chem. Phys. Lipids, vol.164, pp.432-437, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00743454

P. De-medina, M. R. Paillasse, G. Segala, M. Poirot, and S. Silvente-poirot, Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands, Proc. Natl. Acad. Sci. U.S.A, vol.107, pp.13520-13525, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00519159


P. De-medina, S. Silvente-poirot, and M. Poirot, Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation, Autophagy, vol.5, pp.1066-1067, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00519150


P. De-medina, B. Payre, N. Boubekeur, J. Bertrand-michel, F. Terce et al., Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism, Cell Death Differ, vol.16, pp.1372-1384, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00519149

B. Payre, P. De-medina, N. Boubekeur, L. Mhamdi, J. Bertrand-michel et al., Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism, Mol. Cancer Ther, vol.7, pp.3707-3718, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00519145

F. Dalenc, C. Giamarchi, M. Petit, M. Poirot, G. Favre et al., Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways, Breast Cancer Res, vol.7, pp.1159-1167, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00089309

M. Poirot, P. De-medina, F. Delarue, J. J. Perie, A. Klaebe et al., Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS), Bioorg. Med. Chem, vol.8, pp.2007-2016, 2000.
URL : https://hal.archives-ouvertes.fr/inserm-00090778

B. Kedjouar, S. Daunes, B. J. Vilner, W. D. Bowen, A. Klaebe et al., Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor, Biochem. Pharmacol, vol.58, pp.1927-1939, 1999.
URL : https://hal.archives-ouvertes.fr/inserm-00090780

F. Delarue, B. Kedjouar, F. Mesange, F. Bayard, J. C. Faye et al., Modifications of benzylphenoxy ethanamine antiestrogen molecules: influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity, Biochem. Pharmacol, vol.57, pp.657-661, 1999.
URL : https://hal.archives-ouvertes.fr/inserm-00090781

L. J. Brandes, S. P. Bracken, and E. W. Ramsey, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine in combination with cyclophosphamide: an active, low-toxicity regimen for metastatic hormonally unresponsive prostate cancer, J. Clin. Oncol, vol.13, pp.1398-1403, 1995.

M. Poirot, M. Garnier, F. Bayard, I. Riviere, M. Traore et al., The anti-proliferative properties of 4-benzylphenoxy ethanamine derivatives are mediated by the anti-estrogen binding site (ABS), whereas the anti-estrogenic effects of trifluopromazine are not, Biochem. Pharmacol, vol.40, pp.425-429, 1990.
URL : https://hal.archives-ouvertes.fr/inserm-00090799


A. Fargin, F. Bayard, J. C. Faye, M. Traore, M. Poirot et al., Further evidence for a biological role of anti-estrogen-binding sites in mediating the growth inhibitory action of diphenylmethane derivatives, Chem. Biol. Interact, vol.66, pp.101-109, 1988.
URL : https://hal.archives-ouvertes.fr/inserm-00090800


L. J. Brandes, J. M. Gerrard, R. P. Bogdanovic, D. W. Lint, R. E. Reid et al., Correlation of the antiproliferative action of diphenylmethane-derivative antiestrogen binding site ligands with antagonism of histamine binding but not of protein kinase C-mediated phosphorylation, Cancer Res, vol.48, pp.3954-3958, 1988.

L. J. Brandes, A diphenylmethane derivative selective for the anti-estrogen binding site may help define its biological role, Biochem. Biophys. Res. Commun, vol.124, pp.244-249, 1984.

S. Silvente-poirot and M. Poirot, Cancer. Cholesterol and cancer, in the balance, Science, vol.343, pp.1445-1446, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00968924

M. Poirot and S. Silvente-poirot, Cholesterol-5,6-epoxides: chemistry, biochemistry, metabolic fate and cancer, Biochimie, vol.95, pp.622-631, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00743461

M. R. Paillasse, N. Saffon, H. Gornitzka, S. Silvente-poirot, M. Poirot et al., Surprising unreactivity of cholesterol-5,6-epoxides towards nucleophiles, J. Lipid. Res, vol.53, pp.718-725, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00743457

P. De-medina, M. R. Paillasse, B. Payre, S. Silvente-poirot, and M. Poirot, Synthesis of new alkylaminooxysterols with potent cell differentiating activities: identification of leads for the treatment of cancer and neurodegenerative diseases, J. Med. Chem, vol.52, pp.7765-7777, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00519151


F. D. Porter and G. E. Herman, Malformation syndromes caused by disorders of cholesterol synthesis, J. Lipid. Res, vol.52, pp.6-34, 2011.


A. Fransson, P. De-medina, M. R. Paillasse, S. Silvente-poirot, M. Poirot et al., Dendrogenin A and B two new steroidal alkaloids increasing neural responsiveness in the deafened guinea pig, Front. Aging Neurosci, vol.7, p.145, 2015.

S. A. Khalifa, P. De-medina, A. Erlandsson, H. R. El-seedi, S. Silvente-poirot et al., The novel steroidal alkaloids dendrogenin A and B promote proliferation of adult neural stem cells, Biochem. Biophys. Res. Commun, vol.446, pp.681-686, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00968932

M. Friedman, Chemistry and anticarcinogenic mechanisms of glycoalkaloids produced by eggplants, potatoes, and tomatoes, J. Agric. Food Chem, vol.63, pp.3323-3337, 2015.

K. Alhanout, J. M. Rolain, and J. M. Brunel, Squalamine as an example of a new potent antimicrobial agents class: a critical review, Curr. Med. Chem, vol.17, pp.3909-3917, 2010.

G. M. Cragg and D. J. Newman, Natural products: a continuing source of novel drug leads, Biochim. Biophys. Acta, vol.1830, pp.3670-3695, 2013.


T. Watabe and T. Sawahata, Biotransformation of cholesterol to cholestane-3beta,5alpha,6beta-triol via cholesterol alpha-epoxide (5alpha,6alpha-epoxycholestan-3beta-ol) in bovine adrenal cortex, J. Biol. Chem, vol.254, pp.3854-3860, 1979.